🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this single-arm, Phase II interventional clinical trial is to t...
Status
Unknown
Location
West China Hospital, Sichuan University
Start Date
2023-07-01
Trial ID
NCT05978609
Treatments Being Tested
Carboplatin kills cancer cells mainly through induction of DNA damage (drug...
Status
Terminated
Location
University of California Los Angeles
Start Date
2010-12
Trial ID
NCT01261299
Treatments Being Tested
Currently, for further improved survival outcome, new cytotoxic compounds s...
Status
Completed
Location
Severance Hospital, Yonsei University Health System, Yonsei Cancer Center
Start Date
2013-07
Trial ID
NCT02495493
Treatments Being Tested
This is a single arm Phase II study, in which 6 cycles of durvalumab with c...
Status
Unknown
Location
Beijing Haidian Hospital
Start Date
2021-09-01
Trial ID
NCT05034133
Treatments Being Tested
This phase II trial studies the effect of bintrafusp alfa with pemetrexed a...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2021-06-30
Trial ID
NCT04971187
Treatments Being Tested
The investigators conducted a phase II, prospective, two-arm clinical study...
Status
Unknown
Location
Fujian Medical University Union Hospital
Start Date
2023-05-25
Trial ID
NCT05821452
Treatments Being Tested
This is a study to look at whether the presence of circulating tumour DNA (...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2022-03-28
Trial ID
NCT04966663
Treatments Being Tested
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
This is a prospective, multi-center, single arm study assessing the efficac...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2021-01-21
Trial ID
NCT04982549
Treatments Being Tested
Cisplatin and Etoposide is the standard of care in NEC originating from the...
Status
Unknown
Location
S.C. Oncologia - Policlinico
Start Date
2015-05
Trial ID
NCT02687958
Treatments Being Tested